1. Executive Summary
1.1. Global Quinine Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Quinine Market Outlook, 2018 - 2030
3.1. Global Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. 200 mg
3.1.1.2. 300 mg
3.1.1.3. Other
3.2. Global Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Problematic Leg Cramps
3.2.1.2. Malaria
3.2.1.3. Other
3.3. Global Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. Oral Administration
3.3.1.2. Intramuscular Administration
3.3.1.3. Intravenous Administration
3.3.1.4. Others
3.4. Global Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
3.4.1. Key Highlights Snacks
3.4.1.1. Hospitals
3.4.1.2. Clinics
3.4.1.3. Others
3.5. Global Quinine Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Quinine Market Outlook, 2018 - 2030
4.1. North America Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. 200 mg
4.1.1.2. 300 mg
4.1.1.3. Other
4.2. North America Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Problematic Leg Cramps
4.2.1.2. Malaria
4.2.1.3. Other
4.3. North America Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. Oral Administration
4.3.1.2. Intramuscular Administration
4.3.1.3. Intravenous Administration
4.3.1.4. Others
4.4. North America Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
4.4.1. Key Highlights
4.4.1.1. Hospitals
4.4.1.2. Clinics
4.4.1.3. Others
4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
4.5.1. Key Highlights
4.5.1.1. U.S. Quinine Market by Type, Value (US$ Mn), 2018 - 2030
4.5.1.2. U.S. Quinine Market by Application, Value (US$ Mn), 2018 - 2030
4.5.1.3. U.S. Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
4.5.1.4. U.S. Quinine Market by End User, Value (US$ Mn), 2018 - 2030
4.5.1.5. Canada Quinine Market by Type, Value (US$ Mn), 2018 - 2030
4.5.1.6. Canada Quinine Market by Application, Value (US$ Mn), 2018 - 2030
4.5.1.7. Canada Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
4.5.1.8. Canada Quinine Market by End User, Value (US$ Mn), 2018 - 2030
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Quinine Market Outlook, 2018 - 2030
5.1. Europe Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. 200 mg
5.1.1.2. 300 mg
5.1.1.3. Other
5.2. Europe Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Problematic Leg Cramps
5.2.1.2. Malaria
5.2.1.3. Other
5.3. Europe Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Oral Administration
5.3.1.2. Intramuscular Administration
5.3.1.3. Intravenous Administration
5.3.1.4. Others
5.4. Europe Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Clinics
5.4.1.3. Others
5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
5.5.1. Key Highlights
5.5.1.1. Germany Quinine Market by Type, Value (US$ Mn), 2018 - 2030
5.5.1.2. Germany Quinine Market by Application, Value (US$ Mn), 2018 - 2030
5.5.1.3. Germany Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
5.5.1.4. Germany Quinine Market by End User, Value (US$ Mn), 2018 - 2030
5.5.1.5. U.K. Quinine Market by Type, Value (US$ Mn), 2018 - 2030
5.5.1.6. U.K. Quinine Market by Application, Value (US$ Mn), 2018 - 2030
5.5.1.7. U.K. Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
5.5.1.8. U.K. Quinine Market by End User, Value (US$ Mn), 2018 - 2030
5.5.1.9. France Quinine Market by Type, Value (US$ Mn), 2018 - 2030
5.5.1.10. France Quinine Market by Application, Value (US$ Mn), 2018 - 2030
5.5.1.11. France Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
5.5.1.12. France Quinine Market by End User, Value (US$ Mn), 2018 - 2030
5.5.1.13. Italy Quinine Market by Type, Value (US$ Mn), 2018 - 2030
5.5.1.14. Italy Quinine Market by Application, Value (US$ Mn), 2018 - 2030
5.5.1.15. Italy Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
5.5.1.16. Italy Quinine Market by End User, Value (US$ Mn), 2018 - 2030
5.5.1.17. Turkey Quinine Market by Type, Value (US$ Mn), 2018 - 2030
5.5.1.18. Turkey Quinine Market by Application, Value (US$ Mn), 2018 - 2030
5.5.1.19. Turkey Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
5.5.1.20. Turkey Quinine Market by End User, Value (US$ Mn), 2018 - 2030
5.5.1.21. Russia Quinine Market by Type, Value (US$ Mn), 2018 - 2030
5.5.1.22. Russia Quinine Market by Application, Value (US$ Mn), 2018 - 2030
5.5.1.23. Russia Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
5.5.1.24. Russia Quinine Market by End User, Value (US$ Mn), 2018 - 2030
5.5.1.25. Rest of Europe Quinine Market by Type, Value (US$ Mn), 2018 - 2030
5.5.1.26. Rest of Europe Quinine Market by Application, Value (US$ Mn), 2018 - 2030
5.5.1.27. Rest of Europe Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
5.5.1.28. Rest of Europe Quinine Market by End User, Value (US$ Mn), 2018 - 2030
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Quinine Market Outlook, 2018 - 2030
6.1. Asia Pacific Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. 200 mg
6.1.1.2. 300 mg
6.1.1.3. Other
6.2. Asia Pacific Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Problematic Leg Cramps
6.2.1.2. Malaria
6.2.1.3. Other
6.3. Asia Pacific Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. Oral Administration
6.3.1.2. Intramuscular Administration
6.3.1.3. Intravenous Administration
6.3.1.4. Others
6.4. Asia Pacific Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Clinics
6.4.1.3. Others
6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
6.5.1. Key Highlights
6.5.1.1. China Quinine Market by Type, Value (US$ Mn), 2018 - 2030
6.5.1.2. China Quinine Market by Application, Value (US$ Mn), 2018 - 2030
6.5.1.3. China Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
6.5.1.4. China Quinine Market by End User, Value (US$ Mn), 2018 - 2030
6.5.1.5. Japan Quinine Market by Type, Value (US$ Mn), 2018 - 2030
6.5.1.6. Japan Quinine Market by Application, Value (US$ Mn), 2018 - 2030
6.5.1.7. Japan Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
6.5.1.8. Japan Quinine Market by End User, Value (US$ Mn), 2018 - 2030
6.5.1.9. South Korea Quinine Market by Type, Value (US$ Mn), 2018 - 2030
6.5.1.10. South Korea Quinine Market by Application, Value (US$ Mn), 2018 - 2030
6.5.1.11. South Korea Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
6.5.1.12. South Korea Quinine Market by End User, Value (US$ Mn), 2018 - 2030
6.5.1.13. India Quinine Market by Type, Value (US$ Mn), 2018 - 2030
6.5.1.14. India Quinine Market by Application, Value (US$ Mn), 2018 - 2030
6.5.1.15. India Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
6.5.1.16. India Quinine Market by End User, Value (US$ Mn), 2018 - 2030
6.5.1.17. Southeast Asia Quinine Market by Type, Value (US$ Mn), 2018 - 2030
6.5.1.18. Southeast Asia Quinine Market by Application, Value (US$ Mn), 2018 - 2030
6.5.1.19. Southeast Asia Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
6.5.1.20. Southeast Asia Quinine Market by End User, Value (US$ Mn), 2018 - 2030
6.5.1.21. Rest of Asia Pacific Quinine Market by Type, Value (US$ Mn), 2018 - 2030
6.5.1.22. Rest of Asia Pacific Quinine Market by Application, Value (US$ Mn), 2018 - 2030
6.5.1.23. Rest of Asia Pacific Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
6.5.1.24. Rest of Asia Pacific Quinine Market by End User, Value (US$ Mn), 2018 - 2030
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Quinine Market Outlook, 2018 - 2030
7.1. Latin America Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. 200 mg
7.1.1.2. 300 mg
7.1.1.3. Other
7.2. Latin America Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
7.2.1. Key Highlights
7.2.1.1. Problematic Leg Cramps
7.2.1.2. Malaria
7.2.1.3. Other
7.3. Latin America Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Oral Administration
7.3.1.2. Intramuscular Administration
7.3.1.3. Intravenous Administration
7.3.1.4. Others
7.4. Latin America Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Clinics
7.4.1.3. Others
7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
7.5.1. Key Highlights
7.5.1.1. Brazil Quinine Market by Type, Value (US$ Mn), 2018 - 2030
7.5.1.2. Brazil Quinine Market by Application, Value (US$ Mn), 2018 - 2030
7.5.1.3. Brazil Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
7.5.1.4. Brazil Quinine Market by End User, Value (US$ Mn), 2018 - 2030
7.5.1.5. Mexico Quinine Market by Type, Value (US$ Mn), 2018 - 2030
7.5.1.6. Mexico Quinine Market by Application, Value (US$ Mn), 2018 - 2030
7.5.1.7. Mexico Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
7.5.1.8. Mexico Quinine Market by End User, Value (US$ Mn), 2018 - 2030
7.5.1.9. Argentina Quinine Market by Type, Value (US$ Mn), 2018 - 2030
7.5.1.10. Argentina Quinine Market by Application, Value (US$ Mn), 2018 - 2030
7.5.1.11. Argentina Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
7.5.1.12. Argentina Quinine Market by End User, Value (US$ Mn), 2018 - 2030
7.5.1.13. Rest of Latin America Quinine Market by Type, Value (US$ Mn), 2018 - 2030
7.5.1.14. Rest of Latin America Quinine Market by Application, Value (US$ Mn), 2018 - 2030
7.5.1.15. Rest of Latin America Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
7.5.1.16. Rest of Latin America Quinine Market by End User, Value (US$ Mn), 2018 - 2030
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Quinine Market Outlook, 2018 - 2030
8.1. Middle East & Africa Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. 200 mg
8.1.1.2. 300 mg
8.1.1.3. Other
8.2. Middle East & Africa Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Problematic Leg Cramps
8.2.1.2. Malaria
8.2.1.3. Other
8.3. Middle East & Africa Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. Oral Administration
8.3.1.2. Intramuscular Administration
8.3.1.3. Intravenous Administration
8.3.1.4. Others
8.4. Middle East & Africa Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Clinics
8.4.1.3. Others
8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
8.5.1. Key Highlights
8.5.1.1. GCC Quinine Market by Type, Value (US$ Mn), 2018 - 2030
8.5.1.2. GCC Quinine Market by Application, Value (US$ Mn), 2018 - 2030
8.5.1.3. GCC Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
8.5.1.4. GCC Quinine Market by End User, Value (US$ Mn), 2018 - 2030
8.5.1.5. South Africa Quinine Market by Type, Value (US$ Mn), 2018 - 2030
8.5.1.6. South Africa Quinine Market by Application, Value (US$ Mn), 2018 - 2030
8.5.1.7. South Africa Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
8.5.1.8. South Africa Quinine Market by End User, Value (US$ Mn), 2018 - 2030
8.5.1.9. Egypt Quinine Market by Type, Value (US$ Mn), 2018 - 2030
8.5.1.10. Egypt Quinine Market by Application, Value (US$ Mn), 2018 - 2030
8.5.1.11. Egypt Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
8.5.1.12. Egypt Quinine Market by End User, Value (US$ Mn), 2018 - 2030
8.5.1.13. Nigeria Quinine Market by Type, Value (US$ Mn), 2018 - 2030
8.5.1.14. Nigeria Quinine Market by Application, Value (US$ Mn), 2018 - 2030
8.5.1.15. Nigeria Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
8.5.1.16. Nigeria Quinine Market by End User, Value (US$ Mn), 2018 - 2030
8.5.1.17. Rest of Middle East & Africa Quinine Market by Type, Value (US$ Mn), 2018 - 2030
8.5.1.18. Rest of Middle East & Africa Quinine Market by Application, Value (US$ Mn), 2018 - 2030
8.5.1.19. Rest of Middle East & Africa Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
8.5.1.20. Rest of Middle East & Africa Quinine Market by End User, Value (US$ Mn), 2018 - 2030
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs Application Heatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Aecochem Corp
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Haihang Industry Co. Ltd.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Actavis
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Shreeji Pharma International
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Wockhardt
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Vital Labs
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Trademax Pharmaceuticals & Chemicals
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Van Wankum Ingredients
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Hangzhou Dayang Co. Ltd.
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Business Strategies and Development
9.4.10. IS Chemical Technology Ltd.
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Leocorno Enterprises
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Bickford & Sons
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. Fever-Tree
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
9.4.14. Schweppes
9.4.14.1. Company Overview
9.4.14.2. Product Portfolio
9.4.14.3. Financial Overview
9.4.14.4. Business Strategies and Development
9.4.15. Chempro Pharma Private Limited
9.4.15.1. Company Overview
9.4.15.2. Product Portfolio
9.4.15.3. Financial Overview
9.4.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations